Join us as we wrap 2021 with our annual Ophthalmology Year in Review where we will take a look back at all of the notable
deals, approvals, IPOs and M&A transactions, plus provide deeper insights and perspectives from investors, clinical thought leaders, and
industry executives. Throughout the event you will be able to ask questions and make connections with other participants in real time.
PROUDLY SPONSORED BY:
Orasis Pharmaceuticals is an emerging ophthalmic pharmaceutical company focused on developing an innovative eye drop for the treatment of presbyopia symptoms. Promising results from a well powered Phase 2b study have paved an informed path for Orasis to advance their product candidate through successful initiation of Phase 3 studies, NEAR-1 and NEAR-2. Orasis’ differentiated formulation with an optimal balance between efficacy, safety and comfort, along with a proven commercialization strategy in place, positions the company as an emerging leader in the presbyopia space. Follow us on LinkedIn to learn more.